7Baggers
 if you invested $1,000 in y-mabs therapeutics (ymab)  Stock Titan Sat, 04 Jul 2026 04:41:47 GMT
 y-mabs therapeutics inc (ymab) institutional confidence  TradingKey Thu, 18 Jun 2026 03:23:24 GMT
 y-mabs shareholder action reminder  TMX Newsfile Tue, 02 Jun 2026 15:22:31 GMT
 y-mabs shareholder notice  TMX Newsfile Sun, 24 May 2026 13:28:37 GMT
 y-mabs therapeutics, inc. - common stock (nq: ymab  FinancialContent Thu, 14 May 2026 05:55:08 GMT
 y-mabs shareholder action reminder  TMX Newsfile Sat, 25 Apr 2026 07:38:17 GMT
 y-mabs therapeutics stock: what you need to know before buying now  AD HOC NEWS Fri, 03 Apr 2026 07:00:00 GMT
 Y-mAbs terminates radiopharma trial; GSK gets expanded use for Arexvy  Endpoints News Fri, 13 Mar 2026 07:00:00 GMT
 ymab financials: income statement, balance sheet & cash flow  Stock Titan Wed, 25 Feb 2026 18:11:54 GMT
 entry recap: what is the fair value of y mabs therapeutics inc stock now  Bộ Nội Vụ Wed, 14 Jan 2026 00:11:27 GMT
 negative fda adcom vote for y-mabs’ omburtamab  The Pharma Letter Thu, 08 Jan 2026 15:01:12 GMT
 (ymab) risk channels and responsive allocation  Stock Traders Daily Wed, 07 Jan 2026 07:36:01 GMT
 trading the move, not the narrative: (ymab) edition  Stock Traders Daily Sat, 27 Dec 2025 06:14:02 GMT
 y-mabs therapeutics acquisition finalized by serb pharmaceuticals  AD HOC NEWS Mon, 08 Dec 2025 08:00:00 GMT
 y-mabs therapeutics ceo michael rossi sells $20,368 in stock  Investing.com Nigeria Wed, 03 Dec 2025 08:00:00 GMT
 Dr Vignesh Rajah  PharmaTimes Mon, 01 Dec 2025 08:00:00 GMT
 the technical signals behind (ymab) that institutions follow  Stock Traders Daily Mon, 24 Nov 2025 02:02:02 GMT
 vignesh rajah named serb pharmaceuticals’ cmo  The Pharma Letter Wed, 19 Nov 2025 08:00:00 GMT
 precision trading with y-mabs therapeutics inc. (ymab) risk zones  news.stocktradersdaily.com Thu, 13 Nov 2025 00:54:01 GMT
 is y mabs therapeutics inc. stock a dividend growth opportunity  newser.com Sun, 09 Nov 2025 20:08:40 GMT

Y-mAbs Therapeutics, Inc
(NASDAQ:YMAB) 

YMAB stock logo

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophag...

Founded: 2015
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends